Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top Correlated Resources

001060.KS


Top 10 Correlated ETFs

001060.KS


Top 10 Correlated Stocks

001060.KS


Financial details

Company Rating
Strong Buy
Market Cap
385.41B
Income
8.93B
Revenue
639.81B
Book val./share
7720
Cash/share
2626.11
Dividend
325
Dividend %
1.85%
Employees
1.11K
Optionable
No
Shortable
Yes
Earnings
14 Nov 2022
P/E
52.32
Forward P/E
-
PEG
-3.66
P/S
0.73
P/B
2.28
P/C
6.7
P/FCF
12.56
Quick Ratio
0.29
Current Ratio
1.52
Debt / Equity
0.74
LT Debt / Equity
0.79
-
-
EPS (TTM)
289.16
EPS next Y
-
EPS next Q
-
EPS this Y
-93.79%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
3.17%
Revenue last 5Y
3.82%
Revenue Q/Q
5.54%
EPS Q/Q
-59.38%
-
-
-
-
SMA20
-16.99%
SMA50
-26.74%
SMA100
-37.8%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
4%
ROC
0.11%
Gross Margin
39%
Oper. Margin
7%
Profit Margin
1%
Payout
97%
Shs Outstand
21.9M
Shs Float
11.51M
-
-
-
-
Target Price
-
52W Range
16950.0-30950.0
52W High
-43.13%
52W Low
+3.83%
RSI
27
Rel Volume
0.84
Avg Volume
71.92K
Volume
60.46K
Perf Week
-6.88%
Perf Month
-22.12%
Perf Quarter
-37.37%
Perf Half Y
-35.53%
-
-
-
-
Beta
0.229318
-
-
Volatility
310.2%, 1624.07%
Prev Close
0%
Price
17600
Change
0.86%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
24.34K25.78K24.76K25.72K26.32K
Net income per share
-35.93386.68-1.22K-716.15-42
Operating cash flow per share
1.62K2.5K2.69K2.96K786.49
Free cash flow per share
1.09K2.1K2.05K2.26K226.63
Cash per share
1.55K1.49K2.03K2.6K2.85K
Book value per share
13.1K12.48K11.14K9.75K8.73K
Tangible book value per share
12.13K11.76K10.1K8.92K7.25K
Share holders equity per share
13.1K12.48K11.14K9.75K8.73K
Interest debt per share
9.64K8.83K9.63K8.92K10.96K
Market cap
951.1B763.66B557.76B636.4B443.6B
Enterprise value
1109.36B907.94B703.42B808.17B655.38B
P/E ratio
-1.28K94.78-22.07-41.76-458.33
Price to sales ratio
1.891.421.091.160.73
POCF ratio
28.4314.6510.0410.0924.48
PFCF ratio
42.2717.4513.1413.2584.94
P/B Ratio
3.512.942.423.072.2
PTB ratio
3.512.942.423.072.2
EV to sales
2.211.691.381.481.08
Enterprise value over EBITDA
42.1524.8-259.7853.5114.74
EV to operating cash flow
33.1617.4212.6712.8236.16
EV to free cash flow
49.3120.7516.5816.83125.49
Earnings yield
00.01-0.05-0.020
Free cash flow yield
0.020.060.080.080.01
Debt to equity
0.050.180.140.360.61
Debt to assets
0.570.560.60.620.7
Net debt to EBITDA
6.013.94-53.811.374.76
Current ratio
1.51.641.211.281.3
Interest coverage
2.452.48-1.69-0.174.25
Income quality
-45.056.47-2.2-4.14-18.73
Dividend Yield
0.010.010.010.010.02
Payout ratio
-7.930.81-0.27-0.46-7.39
Sales general and administrative to revenue
0.120.120.080.120.14
Research and developement to revenue
0.040.040.050.040.03
Intangibles to total assets
0.030.030.040.030.03
Capex to operating cash flow
-0.33-0.16-0.24-0.24-0.71
Capex to revenue
-0.02-0.02-0.03-0.03-0.02
Capex to depreciation
-0.58-0.47-0.64-0.73-0.8
Stock based compensation to revenue
00000
Graham number
3.25K10.42K17.51K12.53K2.87K
ROIC
0.060.06-0.0600.09
Return on tangible assets
00.01-0.05-0.030
Graham Net
-13.29K-12.1K-12.4K-11.08K-14.22K
Working capital
136.83B145.54B57.07B64.58B83.77B
Tangible asset value
250.64B244.97B208.7B189.8B167.07B
Net current asset value
51.27B40.23B-8.06B-42.29B-78.06B
Invested capital
0.70.670.820.881.22
Average receivables
00000
Average payables
53.74B46.17B46.49B47.89B49.76B
Average inventory
103.91B101.28B95.82B101.2B101.86B
Days sales outstanding
00000
Days payables outstanding
69.247.7146.9947.2650.64
Days of inventory on hand
123.83108.7894.2699.88100.54
Receivables turnover
00000
Payables turnover
5.277.657.777.727.21
Inventory turnover
2.953.363.873.653.63
ROE
00.03-0.11-0.070
Capex per share
-529.94-400.51-634.1-706.65-559.87

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q2

Metric History 2021-06-302021-09-302021-12-312022-03-31 2022-06-30
Revenue per share
6.86K6.59K1.61K1.49K6.22K
Net income per share
-158.13225-63.9391.0937
Operating cash flow per share
0.17997.13124.5854.89347.12
Free cash flow per share
-110.43854.4184.6518.8262.89
Cash per share
2.67K3.06K624.11659.842.63K
Book value per share
9.44K9.13K1.91K1.93K7.72K
Tangible book value per share
8.56K8.3K1.59K1.62K6.47K
Share holders equity per share
9.44K9.13K1.91K1.93K7.72K
Interest debt per share
10.36K9.52K2.36K2.42K9.26K
Market cap
618.54B556.82B2398.92B2877.66B599.96B
Enterprise value
827.6B743.34B2610.7B3096.29B809.06B
P/E ratio
-45.9727.35-89.1675.06152.7
Price to sales ratio
4.243.7414.1618.413.64
POCF ratio
169.72K24.68183.02498.2565.11
PFCF ratio
-263.3128.81269.341.45K85.97
P/B Ratio
3.082.711.9214.152.93
PTB ratio
3.082.711.9214.152.93
EV to sales
5.674.9915.4119.84.9
Enterprise value over EBITDA
156.8158.7167.91173.6659.41
EV to operating cash flow
227.08K32.95199.18536.187.8
EV to free cash flow
-352.338.45293.121.57K115.93
Earnings yield
-0.010.01000
Free cash flow yield
00.03000.01
Debt to equity
0.50.490.610.750.74
Debt to assets
0.660.650.70.70.69
Net debt to EBITDA
39.6114.7313.6212.2615.35
Current ratio
1.391.431.31.461.52
Interest coverage
1.474.574.435.643.39
Income quality
04.43-1.950.69.38
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.140.120.160.140.14
Research and developement to revenue
0.030.040.030.040.04
Intangibles to total assets
0.030.030.030.030.03
Capex to operating cash flow
-645.56-0.14-0.32-0.66-0.24
Capex to revenue
-0.02-0.02-0.02-0.02-0.01
Capex to depreciation
-0.59-0.81-1.04-0.81-0.56
Stock based compensation to revenue
00000
Graham number
5.8K6.8K1.66K1.99K2.54K
ROIC
0.010.020.030.030.02
Return on tangible assets
-0.010.01-0.010.020
Graham Net
-12.8K-11.54K-3.11K-3.06K-11.56K
Working capital
95.65B105.57B83.77B117.4B124.64B
Tangible asset value
182.17B187.89B167.07B170.23B171.8B
Net current asset value
-40.02B-32B-78.06B-74.59B-68.51B
Invested capital
1.091.041.221.241.19
Average receivables
00000
Average payables
51.15B52.68B53B54.36B56.49B
Average inventory
107.79B108.54B104.81B107.1B109.29B
Days sales outstanding
00000
Days payables outstanding
47.7548.4444.7353.1452.84
Days of inventory on hand
108.05104.4588.8104.7100.51
Receivables turnover
00000
Payables turnover
1.881.862.011.691.7
Inventory turnover
0.830.861.010.860.9
ROE
-0.020.02-0.030.050
Capex per share
-110.6-142.72-39.93-36.09-84.22

Frequently Asked Questions

What is JW Pharmaceutical Corporation stock symbol ?

JW Pharmaceutical Corporation is a US stock and trading under the symbol 001060.KS

What is JW Pharmaceutical Corporation stock quote today ?

JW Pharmaceutical Corporation stock price is $17600 today.

Is JW Pharmaceutical Corporation stock public?

Yes, JW Pharmaceutical Corporation is a publicly traded company.

Something similar

Top Correlated ETFs